| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 9.1 | 3.5 |
| Gross profit | 2.1 | 0.6 |
| Profit before tax | -2.5 | -1.9 |
| Net income | -2.5 | -1.9 |
| EPS (diluted, $ a share) | $1.21 | $-509.53 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +161.3% |
|---|---|
| Gross margin | 22.8% |
| Operating margin | -22.0% |
10-Q filed with the SEC, NASDAQ: HCTI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Healthcare Triangle, Inc.: key numbers
- Share price
- $3.38Close, Nov 17
- Market cap
- $3.09M
- Shares outstanding
- 915.19KLatest SEC cover page
- Sector
- Technology
- Industry
- Services-Computer Integrated Systems DesignSIC 7373
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Healthcare Triangle, Inc.
All →Healthcare Triangle Reverse Stock Split
Healthcare Triangle, Inc. effected a 1-for-20 reverse stock split of its common stock effective October 26, 2026. The action reduced the number of outstanding shares from approximately 17.7 million to 886,587 to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
Healthcare Triangle Reverse Stock Split
Healthcare Triangle stockholders approved a proposal to authorize the Board of Directors to effect one or more reverse stock splits at a ratio ranging from 1-for-2 to 1-for-25. Additionally, shareholders approved an amendment to the 2020 Stock Incentive Plan and authorized potential share issuances exceeding 20% of outstanding stock at below-market prices for Nasdaq compliance purposes.
Healthcare Triangle Nasdaq/NYSE Compliance Notice
Healthcare Triangle received a Staff Delisting Determination from Nasdaq on October 1, 2026, for failing to maintain the $1.00 minimum bid price requirement. Because the company has already effected cumulative reverse stock splits exceeding a 1-for-250 ratio over the last two years, it is ineligible for a standard 180-day compliance period. The company intends to appeal the delisting determination to a Nasdaq Hearings Panel, which will stay the suspension of its common stock pending a decision.
- Counterparty
- Nasdaq
Healthcare Triangle Other 8-K Filing
Healthcare Triangle, Inc. entered into an amendment to its existing Equity Purchase Agreement with Hudson Global Ventures, LLC. The amendment modifies administrative terms of the facility, including reducing the maximum amount per put notice from $2.5 million to $250,000 and increasing the minimum share price threshold for draws to $0.10 per share.
- Counterparty
- Hudson Global Ventures, LLC